Watchlists › Dividend Upgrade Candidates › JNJ

Thesis Refresh

Refresh the live thesis, posture, and review state for JNJ without leaving the surrounding evidence, plan, and report context.

Current Posture

Ready

Review Status

Needs Update

Review Date

Feb 28, 2025

Evidence Trail

0 notes linked to this asset

Thesis Decision

Keep the decision record explicit here. Use the side panels when the thesis needs evidence context, operating-plan thresholds, or a deeper report review before the next action.

Action Posture *

Review Status *

Reviewed On *

Core Thesis

Summary Thesis

Bull Case

Bear Case

Action Trigger

Break Condition

Operator Note

Optional. If you fill this in, a concise thesis-review entry is added to the durable review log using the review date above.

Review Note (255 chars max)

Back to Watchlist

Evidence Snapshot

0 research notes on file

Research + Add First Note

No research notes are on file for this asset yet. Add evidence before treating the thesis as well-supported.

Operating Plan

Edit Plan

Upgrade JNJ only if the defensive income thesis still offsets litigation and pipeline risk; otherwise stand aside.

$154.00 $175.00

Invalidate $165.00 Entry Low $154.00 Entry High $160.00 Trim $175.00 Current $161.26

Entry: +0.8% above zone Trim: +8.5% to target Risk: +2.3% below invalidation

Review Apr 24, 2026 38 days overdue Cadence 30d

Entry Zone $154.00 - $160.00

Trim $175.00

Invalidate $165.00

Monitor: Review litigation reserve updates, MedTech execution, and dividend coverage before the next decision.

Execution: If the invalidation threshold stays broken, do not average down until the thesis is rewritten.

Use adjacent research, report, and plan surfaces when this thesis refresh needs deeper operating context.

Recent Reviews

No review-log entries are recorded yet for this item. Open the full review log flow when you need a longer decision record.